MUX vs UAMY: Which Stock Is the Better Buy?
McEwen Inc. and United States Antimony Corporation side by side — fundamentals from SEC filings, refreshed nightly. Sector: Basic Materials.
AI verdict — MUX vs UAMY, read from the filings
The stronger business, the cheaper stock, and the risks — synthesised from both companies’ SEC filings, every figure computed not guessed. Not investment advice.
| McEwen Inc. (MUX) | United States Antimony Corporation (UAMY) | |
|---|---|---|
| Market cap | $1.1B | $1.0B |
| Revenue (latest FY) | $197.55M | $39.26M |
| Net income (latest FY) | $34.43M | $-4.34M |
| Revenue growth (5y CAGR) | 13.5% | 49.6% |
| Net margin | 17.4% | -11.1% |
| Return on equity | 6.3% | -3.1% |
| P/E ratio | 14.9 | — |
| Dividend yield | — | — |
| Profitable years (of last 10) | 3 | 2 |
| Positive free cash flow | No | No |
Verify the comparison
Use the filing period and source shown by each tool before treating two figures as comparable.
See the full MUX vs UAMY breakdown
Both companies across 19 years of income statement, balance sheet and cash flow — with ratios, health checks and Ask, the SEC-grounded research assistant. Free, no account needed.
Open MUX's full financials → Open UAMY's full financials →More comparisons
Frequently asked questions
Which is bigger, MUX or UAMY?
McEwen Inc. is larger by market capitalization — $1.1B versus $1.0B.
Which grows faster, MUX or UAMY?
Over the last five fiscal years, United States Antimony Corporation grew revenue faster — 49.6%/yr versus 13.5%/yr, computed from SEC-filed statements.
Where does this data come from?
All figures are computed from official SEC filings (10-K), refreshed nightly. This is a data comparison, not investment advice.